TEVA logo

TEVA Cash From Investing

Annual CFI:

-$565.67M-$56.67M(-11.13%)
December 31, 2024

Summary

  • As of today, TEVA annual cash from investing is -$565.67 million, with the most recent change of -$56.67 million (-11.13%) on December 31, 2024.
  • During the last 3 years, TEVA annual cash from investing has fallen by -$440.67 million (-352.54%).
  • TEVA annual cash from investing is now -125.94% below its all-time high of $2.18 billion, reached on December 31, 2017.

Performance

TEVA Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAcash flow metrics

Quarterly CFI:

-$139.82M-$37.78M(-37.02%)
September 30, 2025

Summary

  • As of today, TEVA quarterly cash from investing is -$139.82 million, with the most recent change of -$37.78 million (-37.02%) on September 30, 2025.
  • Over the past year, TEVA quarterly cash from investing has dropped by -$68.82 million (-96.93%).
  • TEVA quarterly cash from investing is now -109.10% below its all-time high of $1.54 billion, reached on March 31, 2017.

Performance

TEVA Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAcash flow metrics

TTM CFI:

-$538.86M-$68.82M(-14.64%)
September 30, 2025

Summary

  • As of today, TEVA TTM cash from investing is -$538.86 million, with the most recent change of -$68.82 million (-14.64%) on September 30, 2025.
  • Over the past year, TEVA TTM cash from investing has increased by +$6.14 million (+1.13%).
  • TEVA TTM cash from investing is now -122.31% below its all-time high of $2.41 billion, reached on September 30, 2018.

Performance

TEVA TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

TEVA Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-11.1%-96.9%+1.1%
3Y3 Years-352.5%-21.6%-10.0%
5Y5 Years-328.5%+20.6%-63.8%

TEVA Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-352.5%at low-105.0%+35.0%-22.5%+17.0%
5Y5-Year-352.5%at low-284.0%+35.0%-331.1%+17.0%
All-TimeAll-Time-125.9%+98.4%-109.1%+99.6%-122.3%+98.5%

TEVA Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2025
-
-$139.82M(-37.0%)
-$538.86M(-14.6%)
Jun 2025
-
-$102.04M(+35.8%)
-$470.04M(+7.3%)
Mar 2025
-
-$159.00M(-15.2%)
-$507.00M(+9.9%)
Dec 2024
-$565.67M(-11.1%)
-$138.00M(-94.4%)
-$563.00M(-3.3%)
Sep 2024
-
-$71.00M(+48.9%)
-$545.00M(+16.1%)
Jun 2024
-
-$139.00M(+35.3%)
-$649.31M(-12.2%)
Mar 2024
-
-$215.00M(-79.2%)
-$578.51M(-14.7%)
Dec 2023
-$509.00M(-5.6%)
-$120.00M(+31.5%)
-$504.18M(-0.8%)
Sep 2023
-
-$175.31M(-157.0%)
-$500.28M(-13.7%)
Jun 2023
-
-$68.20M(+51.5%)
-$439.98M(+8.1%)
Mar 2023
-
-$140.67M(-21.2%)
-$478.78M(+0.7%)
Dec 2022
-$482.11M(-285.7%)
-$116.11M(-1.0%)
-$482.11M(+1.6%)
Sep 2022
-
-$115.00M(-7.5%)
-$490.00M(-1.2%)
Jun 2022
-
-$107.00M(+25.7%)
-$484.00M(-60.8%)
Mar 2022
-
-$144.00M(-16.1%)
-$301.00M(-140.8%)
Dec 2021
-$125.00M(+76.9%)
-$124.00M(-13.8%)
-$125.00M(+23.3%)
Sep 2021
-
-$109.00M(-243.4%)
-$163.00M(+29.1%)
Jun 2021
-
$76.00M(+137.5%)
-$230.00M(+41.6%)
Mar 2021
-
$32.00M(+119.8%)
-$394.00M(+27.3%)
Dec 2020
-$542.00M(-310.6%)
-$162.00M(+8.0%)
-$542.00M(-64.7%)
Sep 2020
-
-$176.00M(-100.0%)
-$329.00M(-12.5%)
Jun 2020
-
-$88.00M(+24.1%)
-$292.32M(-83.8%)
Mar 2020
-
-$116.00M(-327.5%)
-$159.03M(-19.2%)
Dec 2019
-$132.00M(-201.1%)
$51.00M(+136.6%)
-$133.39M(+92.8%)
Sep 2019
-
-$139.32M(-407.6%)
-$1.85B(-373.9%)
Jun 2019
-
$45.29M(+150.1%)
-$389.49M(+61.0%)
Mar 2019
-
-$90.36M(+94.6%)
-$999.71M(-876.9%)
Dec 2018
$130.57M(-94.0%)
-$1.66B(-226.2%)
$128.69M(-94.7%)
Sep 2018
-
$1.32B(+333.1%)
$2.41B(+100.3%)
Jun 2018
-
-$564.93M(-154.4%)
$1.21B(-28.3%)
Mar 2018
-
$1.04B(+66.1%)
$1.68B(-22.9%)
Dec 2017
$2.18B(+106.1%)
$624.88M(+479.8%)
$2.18B(+187.4%)
Sep 2017
-
$107.77M(+222.0%)
$758.93M(+102.4%)
Jun 2017
-
-$88.34M(-105.7%)
-$31.65B(+0.4%)
Mar 2017
-
$1.54B(+292.8%)
-$31.79B(+11.1%)
Dec 2016
-$35.86B(-544.4%)
-$797.00M(+97.5%)
-$35.74B(-1.4%)
Sep 2016
-
-$32.30B(>-9900.0%)
-$35.24B(-1047.4%)
Jun 2016
-
-$225.00M(+90.7%)
-$3.07B(+60.4%)
Mar 2016
-
-$2.42B(-724.9%)
-$7.76B(-39.5%)
Dec 2015
-$5.57B(-283.8%)
-$293.00M(-115.4%)
-$5.57B(+1.0%)
Sep 2015
-
-$136.00M(+97.2%)
-$5.62B(+6.5%)
Jun 2015
-
-$4.92B(-2145.2%)
-$6.01B(-369.2%)
Mar 2015
-
-$219.00M(+36.9%)
-$1.28B(+11.7%)
Dec 2014
-$1.45B(-26.5%)
-$347.00M(+34.3%)
-$1.45B(-2.9%)
Sep 2014
-
-$528.00M(-182.4%)
-$1.41B(-20.2%)
Jun 2014
-
-$187.00M(+51.8%)
-$1.17B(+7.0%)
Mar 2014
-
-$388.00M(-26.6%)
-$1.26B(-9.9%)
Dec 2013
-$1.15B(-1.5%)
-$306.38M(-5.2%)
-$1.15B(+8.3%)
Sep 2013
-
-$291.34M(-6.1%)
-$1.25B(-3.2%)
Jun 2013
-
-$274.68M(-0.2%)
-$1.21B(+0.5%)
Mar 2013
-
-$274.19M(+33.2%)
-$1.22B(-7.8%)
Dec 2012
-$1.13B
-$410.20M(-62.1%)
-$1.13B(+81.7%)
DateAnnualQuarterlyTTM
Sep 2012
-
-$253.04M(+10.0%)
-$6.17B(+13.0%)
Jun 2012
-
-$281.07M(-51.5%)
-$7.09B(-0.6%)
Mar 2012
-
-$185.52M(+96.6%)
-$7.05B(+6.7%)
Dec 2011
-$7.56B(-38.8%)
-$5.45B(-363.5%)
-$7.56B(-225.0%)
Sep 2011
-
-$1.18B(-392.4%)
-$2.33B(+62.7%)
Jun 2011
-
-$238.89M(+65.4%)
-$6.24B(-7.4%)
Mar 2011
-
-$690.95M(-214.8%)
-$5.81B(-6.7%)
Dec 2010
-$5.45B(-495.7%)
-$219.50M(+95.7%)
-$5.45B(+1.0%)
Sep 2010
-
-$5.09B(-2803.5%)
-$5.50B(-647.9%)
Jun 2010
-
$188.15M(+157.4%)
-$735.41M(+32.9%)
Mar 2010
-
-$327.74M(-19.7%)
-$1.10B(-20.0%)
Dec 2009
-$914.21M(+78.0%)
-$273.71M(+15.0%)
-$913.13M(+79.6%)
Sep 2009
-
-$322.11M(-86.6%)
-$4.48B(-4.0%)
Jun 2009
-
-$172.63M(-19.3%)
-$4.31B(+1.5%)
Mar 2009
-
-$144.68M(+96.2%)
-$4.37B(-6.3%)
Dec 2008
-$4.15B(-208.7%)
-$3.84B(-2444.5%)
-$4.12B(-490.7%)
Sep 2008
-
-$150.89M(+36.9%)
-$696.71M(+8.2%)
Jun 2008
-
-$239.29M(-309.4%)
-$759.34M(-41.7%)
Mar 2008
-
$114.27M(+127.2%)
-$535.96M(+60.2%)
Dec 2007
-$1.34B(+66.7%)
-$420.80M(-97.1%)
-$1.35B(-55.1%)
Sep 2007
-
-$213.52M(-1241.9%)
-$867.95M(+29.8%)
Jun 2007
-
-$15.91M(+97.7%)
-$1.24B(+20.0%)
Mar 2007
-
-$695.89M(-1313.0%)
-$1.54B(+61.8%)
Dec 2006
-$4.04B(-649.2%)
$57.37M(+109.9%)
-$4.04B(+2.3%)
Sep 2006
-
-$581.34M(-79.4%)
-$4.13B(-5.6%)
Jun 2006
-
-$324.10M(+89.8%)
-$3.91B(-6.8%)
Mar 2006
-
-$3.19B(-8629.7%)
-$3.66B(-579.7%)
Dec 2005
-$538.94M(+77.5%)
-$36.54M(+89.9%)
-$538.94M(+42.7%)
Sep 2005
-
-$360.83M(-375.1%)
-$940.61M(-38.5%)
Jun 2005
-
-$75.95M(-15.7%)
-$678.92M(+16.3%)
Mar 2005
-
-$65.62M(+85.0%)
-$811.08M(+66.2%)
Dec 2004
-$2.40B(-454.1%)
-$438.21M(-342.0%)
-$2.40B(-23.9%)
Sep 2004
-
-$99.14M(+52.4%)
-$1.93B(-5.4%)
Jun 2004
-
-$208.11M(+87.4%)
-$1.84B(-12.8%)
Mar 2004
-
-$1.65B(-6876.1%)
-$1.63B(-6776.1%)
Dec 2003
-$432.67M(+35.0%)
$24.38M(+114.3%)
$24.38M(+105.5%)
Dec 2002
-$666.14M(-249.4%)
-
-
Jun 2002
-
-$170.20M(-1.1%)
-$447.22M(-35.7%)
Mar 2002
-
-$168.30M(-143.0%)
-$329.49M(-72.8%)
Dec 2001
-$190.65M(-126.1%)
-$69.25M(-75.5%)
-$190.65M(-57.0%)
Sep 2001
-
-$39.47M(+24.8%)
-$121.40M(-48.2%)
Jun 2001
-
-$52.46M(-78.0%)
-$81.93M(-178.0%)
Mar 2001
-
-$29.47M
-$29.47M
Dec 2000
-$84.31M(+92.5%)
-
-
Dec 1999
-$1.12B(-126.5%)
-
-
Dec 1998
-$495.81M(-657.6%)
-
-
Dec 1997
-$65.44M(+48.6%)
-
-
Dec 1996
-$127.23M(-2.3%)
-
-
Dec 1995
-$124.40M(-63.5%)
-
-
Dec 1994
-$76.09M(-27.2%)
-
-
Dec 1993
-$59.81M(-15.9%)
-
-
Dec 1992
-$51.61M(-6.9%)
-
-
Dec 1991
-$48.30M
-
-

FAQ

  • What is Teva Pharmaceutical Industries Limited annual cash from investing?
  • What is the all-time high annual cash from investing for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited annual cash from investing year-on-year change?
  • What is Teva Pharmaceutical Industries Limited quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited quarterly cash from investing year-on-year change?
  • What is Teva Pharmaceutical Industries Limited TTM cash from investing?
  • What is the all-time high TTM cash from investing for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited TTM cash from investing year-on-year change?

What is Teva Pharmaceutical Industries Limited annual cash from investing?

The current annual cash from investing of TEVA is -$565.67M

What is the all-time high annual cash from investing for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high annual cash from investing is $2.18B

What is Teva Pharmaceutical Industries Limited annual cash from investing year-on-year change?

Over the past year, TEVA annual cash from investing has changed by -$56.67M (-11.13%)

What is Teva Pharmaceutical Industries Limited quarterly cash from investing?

The current quarterly cash from investing of TEVA is -$139.82M

What is the all-time high quarterly cash from investing for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high quarterly cash from investing is $1.54B

What is Teva Pharmaceutical Industries Limited quarterly cash from investing year-on-year change?

Over the past year, TEVA quarterly cash from investing has changed by -$68.82M (-96.93%)

What is Teva Pharmaceutical Industries Limited TTM cash from investing?

The current TTM cash from investing of TEVA is -$538.86M

What is the all-time high TTM cash from investing for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high TTM cash from investing is $2.41B

What is Teva Pharmaceutical Industries Limited TTM cash from investing year-on-year change?

Over the past year, TEVA TTM cash from investing has changed by +$6.14M (+1.13%)
On this page